Cellectar Biosciences adopts 2021 Stock Incentive Plan
Cellectar Biosciences, Inc. filed an exhibit adopting the 2021 Stock Incentive Plan. The document outlines terms for granting stock awards to officers, employees, and service providers to align their interests with those of stockholders.
View filing at SEC.gov →